Massive Congrats HDAX Therapeutics! 🙌 HDAX Therapeutics focuses on developing epigenetic-targeting treatments through designing and synthesizing the next generation of life-improving medicines.

We had a fantastic chat with Donovan Bailey at #UofTEntWeek hosted by University of Toronto Entrepreneurship and excited to be 1st prize winners of the 2022 #UofTStartupPrize pitch competition

Congrats HDAX Therapeutics, who also came in 1st place at our Building a Biotech Venture pitch competition last year, on winning the #UofTStartupPrize. Great work by all these teams!

On March 24, H2i's FemSTEM series wrapped up with the 2022 Pitch Competition! We would like to congratulate our grand prize winner Rebecca Allan, PhD of SciVance, 1st runner up Nabanita Nawar, PhD of HDAX Therapeutics, and 2nd runner up, Jennifer Doucet of Glusyn Diagnostics! 🥳

Toutes nos félicitations à HDAX Therapeutics, qui a gagné le Grand Prix du Concours pan-Canadien de pitchs pour start-ups d'un montant de 20 000$ commandité par @pfizerCA !

We are very proud to introduce the Duchenne Muscular Dystrophy Research Fund at the University of Toronto. At Max's Big Ride we strongly believe in fundraising to create unique opportunities to further research and create better outcomes for those living with Duchenne. For the past five years...

The final version of our PhD student Geordi Frere's MCB chapter on molecular glue degraders is online! Thanks Arun K. Shukla for editing this book and giving us the opportunity to detail the fascinating history and future of #molecularglue #degraders! sciencedirect.com/science/articl…

Excellent review of the different molecular glue mechanisms discovered to date - essential reading - everything is there....#proteindegradation #PFEColleague bit.ly/3MNFxd0

Max's Big Ride is back! We are excited to announce that we are returning for our 8th annual ride from Mon, June 27 to Fri, July 1. We will once again be riding from home where Andrew will log 120km per day on his bicycle trainer for a total of..

"Serendegrity" is born! Just swooned when reading this thoughtful must-read reflection on the re-emergent pharmacology of molecular glues by Gunning Group. Thx Fred for sending. sciencedirect.com/science/articl…

Max's Big Ride starts tomorrow! 120 km a day until Canada Day to raise awareness and funds for the Duchenne Muscular Dystrophy Research Fund! maxsbigride.com

A Huge Thank You to Brain Cancer Canada and their incredible donors for supporting our research! Great to meet the amazing and dedicated team, especially Angela Scalisi, and thank you Sheila Singh Brain Tumour Lab for collaborating with us on our HDAC program

Our visiting scholar Helena Sorger from the Moriggl lab Vetmeduni was featured in The Cancer Researcher EACR on her experience in our lab University of Toronto as an EACR Travel Fellow! Can't wait to read her first-author paper just submitted to EMBO Mol. Medicine! magazine.eacr.org/a-personal-hig…

Check out our work over the past three years with the JAKSTAT-Target consortium. The video was made by our talented Masters Student Bilal Saqib for the ERA-Net PerMed video competition. Public voting is by Youtube Likes! youtube.com/watch?v=DIDkmq…

The beacons are lit, and #chemtwitter will answer!!

Remembering former Mississauga mayor and the namesake of the UTM Library, Hazel McCallion. Hazel was a passionate advocate for education and innovation U of T Mississauga and Mississauga, inspiring us with her words and force of personality during a visit to our lab in 2018.

We are delighted to announce the incorporation of RIANA Therapeutics GmbH, a biotech startup focused on developing novel anti-cancer treatments. For more information about RIANA Therapeutics GmbH, please visit rianatx.com.

Thrilled to share our #OpenAccess online resource "An Introduction to Medicinal Chemistry & Molecular Recognition" on eCampusOntario Open Library! We designed this resource to provide budding medicinal chemists with the knowledge & tools to navigate small molecule drug discovery! #OER